Detalles de la búsqueda
1.
Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer.
Oncology
; 102(3): 271-282, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725914
2.
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.
Int J Clin Oncol
; 29(2): 124-133, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160406
3.
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
Invest New Drugs
; 40(5): 1066-1079, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749041
4.
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B).
Int J Clin Oncol
; 27(1): 112-120, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34643820
5.
Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.
Oncology
; 99(9): 562-570, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237736
6.
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma.
Chemotherapy
; 66(3): 65-71, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827084
7.
Clinical Effectiveness of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with a Poor Performance Status.
Medicina (Kaunas)
; 57(11)2021 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34833490
8.
Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.
Oncologist
; 25(4): e668-e674, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771990
9.
A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer patients with PS 2 up to 74 years old and patients with PS 0 or 1 from 75 years: NEJ039A (trial in progress).
BMC Cancer
; 20(1): 961, 2020 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33023530
10.
Evaluation of a chest rehabilitation project in Nepal using the St. George's Respiratory Questionnaire and Chronic Obstructive Pulmonary Disease Assessment Test.
J Phys Ther Sci
; 32(12): 795-799, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33362348
11.
Correction to: Osimertinib in poor performance status patients with T790Mpositive advanced nonsmallcell lung cancer after progression of first- and secondgeneration EGFRTKI treatments (NEJ032B).
Int J Clin Oncol
; 27(4): 823-824, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35257278
12.
Synchronous dilemma of sarcoid-like reaction and drastic response after PD-1 blockade administration in lung cancer.
Jpn J Clin Oncol
; 51(7): 1179-1180, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33774678
13.
[An Elderly Patient with Non-Small Cell Lung Cancer Who Responded to Salvage S-1 Monotherapy after Gefitinib Therapy].
Gan To Kagaku Ryoho
; 42(9): 1091-3, 2015 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-26469166
14.
Progression to Lymph Node Metastasis After Spontaneous Regression of Pulmonary Adenocarcinoma Following Biopsy.
In Vivo
; 38(3): 1498-1502, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38688648
15.
Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in nonsmall cell lung cancer treated with immunotherapy.
Oncol Lett
; 27(3): 110, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38304175
16.
Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab.
Cancers (Basel)
; 16(7)2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38611087
17.
Metabolic Tumor Volume as Significant Predictor for Chemotherapy Containing PD-L1 Blocker in Extensive Stage Small Cell Lung Cancer.
Anticancer Res
; 44(4): 1541-1551, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537960
18.
Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib.
Thorac Cancer
; 14(29): 2950-2961, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37605832
19.
Prognostic significance of tumor infiltrating lymphocytes on first-line pembrolizumab efficacy in advanced non-small cell lung cancer.
Discov Oncol
; 14(1): 6, 2023 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36662367
20.
Intermittent administration of atezolizumab with combined carboplatin and etoposide therapy for patients with extensivedisease small cell lung cancer.
Oncol Lett
; 25(3): 111, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36817046